Versor Investments LP Invests $453,000 in Xylem Inc. (NYSE:XYL)

Versor Investments LP purchased a new position in shares of Xylem Inc. (NYSE:XYLGet Rating) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 4,100 shares of the industrial products company’s stock, valued at approximately $453,000.

Several other large investors also recently made changes to their positions in the stock. First Trust Advisors LP boosted its stake in Xylem by 399.3% during the 1st quarter. First Trust Advisors LP now owns 2,951,349 shares of the industrial products company’s stock valued at $251,632,000 after purchasing an additional 2,360,214 shares during the period. Vanguard Group Inc. raised its holdings in shares of Xylem by 7.6% in the 1st quarter. Vanguard Group Inc. now owns 20,390,911 shares of the industrial products company’s stock worth $1,738,529,000 after buying an additional 1,435,798 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Xylem by 53.6% in the 1st quarter. Invesco Ltd. now owns 3,828,177 shares of the industrial products company’s stock worth $326,390,000 after buying an additional 1,335,241 shares in the last quarter. Renaissance Technologies LLC raised its holdings in shares of Xylem by 613.3% in the 1st quarter. Renaissance Technologies LLC now owns 1,183,400 shares of the industrial products company’s stock worth $100,897,000 after buying an additional 1,017,500 shares in the last quarter. Finally, Robeco Schweiz AG raised its holdings in shares of Xylem by 159.6% in the 1st quarter. Robeco Schweiz AG now owns 648,700 shares of the industrial products company’s stock worth $55,308,000 after buying an additional 398,855 shares in the last quarter. Institutional investors own 83.57% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on XYL. Citigroup decreased their price target on Xylem from $123.00 to $121.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 8th. Cowen increased their price objective on Xylem from $115.00 to $120.00 and gave the company an “outperform” rating in a research report on Tuesday, February 14th. Morgan Stanley lifted their price objective on Xylem from $105.00 to $115.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 18th. Raymond James cut Xylem from a “market perform” rating to an “underperform” rating in a research note on Wednesday, January 4th. Finally, TheStreet raised Xylem from a “c” rating to a “b” rating in a research note on Tuesday, February 7th. One analyst has rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $114.80.

Insider Activity

In related news, SVP Hayati Yarkadas sold 15,942 shares of the stock in a transaction that occurred on Thursday, March 2nd. The stock was sold at an average price of $100.43, for a total transaction of $1,601,055.06. Following the sale, the senior vice president now owns 12,146 shares of the company’s stock, valued at $1,219,822.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In related news, CEO Patrick Decker sold 56,298 shares of the stock in a transaction that occurred on Monday, March 13th. The stock was sold at an average price of $98.19, for a total transaction of $5,527,900.62. Following the sale, the chief executive officer now owns 287,564 shares of the company’s stock, valued at $28,235,909.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Hayati Yarkadas sold 15,942 shares of the stock in a transaction that occurred on Thursday, March 2nd. The stock was sold at an average price of $100.43, for a total value of $1,601,055.06. Following the sale, the senior vice president now directly owns 12,146 shares in the company, valued at approximately $1,219,822.78. The disclosure for this sale can be found here. 0.89% of the stock is owned by company insiders.

Xylem Price Performance

Xylem stock opened at $104.58 on Friday. Xylem Inc. has a 12 month low of $72.08 and a 12 month high of $118.58. The stock’s 50 day moving average is $102.25 and its 200-day moving average is $104.16. The company has a current ratio of 1.89, a quick ratio of 1.39 and a debt-to-equity ratio of 0.54. The company has a market capitalization of $18.89 billion, a price-to-earnings ratio of 53.36, a PEG ratio of 2.69 and a beta of 1.08.

Xylem (NYSE:XYLGet Rating) last posted its earnings results on Tuesday, February 7th. The industrial products company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.79 by $0.13. Xylem had a return on equity of 15.72% and a net margin of 6.43%. The company had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter in the prior year, the business earned $0.63 earnings per share. The firm’s revenue for the quarter was up 13.8% on a year-over-year basis. Equities research analysts expect that Xylem Inc. will post 3.18 EPS for the current year.

Xylem Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 22nd. Stockholders of record on Wednesday, February 22nd were given a $0.33 dividend. This is an increase from Xylem’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Tuesday, February 21st. This represents a $1.32 annualized dividend and a dividend yield of 1.26%. Xylem’s dividend payout ratio is presently 67.35%.

Xylem Profile

(Get Rating)

Xylem, Inc engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.